Suppr超能文献

心脏性猝死的分子尸检

Molecular autopsy in sudden cardiac death.

作者信息

Campuzano Oscar, Sarquella-Brugada Georgia

机构信息

Medical Science Department, School of Medicine, Universitat de Girona, 17003 Girona, Spain.

Cardiovascular Genetics Center, University of Girona-IDIBGI, 17190 Girona, Spain.

出版信息

Glob Cardiol Sci Pract. 2023 Jan 30;2023(1):e202308. doi: 10.21542/gcsp.2023.8.

Abstract

A post-mortem genetic analysis in the process of investigating a sudden death episode is known as 'molecular autopsy'. It is usually performed in cases without a conclusive cause of death and after a comprehensive medico-legal autopsy. In these sudden unexplained death cases, an underlying inherited arrhythmogenic cardiac disease is the main suspected cause of death. The objective is to unravel a genetic diagnosis of the victim, but it also enables cascade genetic screening of the victim's relatives. Early identification of a deleterious genetic alteration associated with an inherited arrhythmogenic disease may help to adopt preventive personalized measures to reduce risk of malignant arrhythmias and sudden death. It is important to remark that the first symptom of an inherited arrhythmogenic cardiac disease may the malignant arrhythmia and even sudden death. Next-generation sequencing allows a rapid and cost-effectives genetic analysis. Close interaction between the forensic scientist, pathologist, cardiologist, pediatric cardiologist and geneticist has allowed a progressive increase of genetic yield in recent years, identifying the pathogenic genetic alteration. However, large numbers of rare genetic alterations remain classified as having an ambiguous role, impeding a proper genetic interpretation and useful translation into both forensic and cardiological arena.

摘要

在调查猝死事件过程中进行的尸检基因分析被称为“分子尸检”。它通常在死因不明且经过全面的法医学尸检后进行。在这些不明原因的猝死病例中,潜在的遗传性致心律失常性心脏病是主要的可疑死因。其目的是明确受害者的基因诊断,但也能对受害者的亲属进行级联基因筛查。早期识别与遗传性致心律失常性疾病相关的有害基因改变,可能有助于采取预防性的个性化措施,以降低恶性心律失常和猝死的风险。需要指出的是,遗传性致心律失常性心脏病的首发症状可能就是恶性心律失常甚至猝死。新一代测序技术能够实现快速且经济高效的基因分析。近年来,法医、病理学家、心脏病专家、儿科心脏病专家和遗传学家之间的密切合作使得基因检测阳性率逐步提高,从而确定致病基因改变。然而,大量罕见的基因改变仍被归类为作用不明确,这阻碍了恰当的基因解读以及在法医和心脏病学领域的有效应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce9a/9988296/60fba8d915d3/gcsp-2023-1-e202308-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验